Publications

2024

Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population

Cereja-Pantoja KBC, de Brito Azevedo TC, Vinagre LWMS, de Moraes FCA, da Costa Nunes GG, Monte N, de Alcântara AL, Cohen-Paes A, Fernandes MR, Batista Dos Santos SE, de Assumpção PP, Ribeiro Dos Santos ÂK, Burbano RMR, Guerrero RC, Carracedo Á, Carneiro Dos Santos NP

Cancer Chemother Pharmacol. 2024 Sep;94(3):387-395

Genomics and Bioinformatics

Alternative translation initiation by ribosomal leaky scanning produces multiple isoforms of the Pif1 helicase.

Lama-Diaz T, Blanco MG

Nucleic Acids Research. 2024 May 23:gkae400

DNA Repair and Genome Integrity

Association between endocrine and neuropsychological endophenotypes and gambling disorder severity

Mora-Maltas B, Baenas I, Etxandi M, Lucas I, Granero R, Fernández-Aranda F, Tovar S, Solé-Morata N, Gómez-Peña M, Moragas L, Del Pino-Gutiérrez A, Tapia J, Diéguez C, Goudriaan AE, Jiménez-Murcia S.

Addict Behav. 2024 Jun;153:107968

Diabesity, Functional Obesomics

Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models

Lara García-Varela, Jessica Codesido, Alberto Perez-Pedrosa, María Muñoz-González, Emma Ramos-Docampo, David Rey-Bretal, Xurxo García-Otero, Noemí Gómez-Lado, Angela Turrero, Daniel Beiroa, Ana Isabel Rodríguez-Perez, Anxo Vidal, Anxo Fernández-Ferreiro, Virginia Pubul, Pablo Aguiar

International Journal of Pharmaceutics. Volume 652, 5 March 2024, 123795

Cell cycle and Oncology, Molecular Imaging Biomarkers and Theragnosis Lab

Biodistribution and pharmacokinetics of [⁸⁹Zr]-anti-VEGF mAbs using PET in glioblastoma rat models.

International Journal of Pharmaceutics, Volume 652, 2024,123795, ISSN 0378-5173.

Molecular Imaging Biomarkers and Theragnosis Lab